Sagimet Biosciences Inc.
SGMT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $2,000 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $2,000 | $0 | $0 |
| % Margin | – | 100% | – | – |
| R&D Expenses | $38,444 | $19,777 | $24,919 | $19,340 |
| G&A Expenses | $16,010 | $12,963 | $6,136 | $4,379 |
| SG&A Expenses | $16,010 | $12,963 | $6,136 | $4,379 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $54,454 | $32,740 | $31,055 | $23,719 |
| Operating Income | -$54,454 | -$30,740 | -$31,055 | -$23,719 |
| % Margin | – | -1,537% | – | – |
| Other Income/Exp. Net | $8,887 | $2,864 | $556 | -$723 |
| Pre-Tax Income | -$45,567 | -$27,876 | -$30,499 | -$24,442 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$45,567 | -$27,876 | -$30,499 | -$24,442 |
| % Margin | – | -1,393.8% | – | – |
| EPS | -1.45 | -1.53 | -1.38 | -1.1 |
| % Growth | 5.2% | -10.9% | -25.5% | – |
| EPS Diluted | -1.45 | -1.53 | -1.38 | -1.1 |
| Weighted Avg Shares Out | 31,351 | 18,195 | 22,174 | 22,174 |
| Weighted Avg Shares Out Dil | 31,351 | 18,195 | 22,174 | 22,174 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2,860 | $553 | $26 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$45,567 | -$30,740 | -$31,055 | -$23,719 |
| % Margin | – | -1,537% | – | – |